Prescription drug · UNAPPROVED DRUG OTHER
EvexiTHROID (Levothyroxine and liothyronine) NDC 73352-695
Levothyroxine 28.5 ug/1; Liothyronine 6.75 ug/1 · Tablet · Oral · Trifluent Pharma, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 73352-695-10 | 73352069510 | 100 TABLET in 1 BOTTLE (73352-695-10)Marketed from Oct 12, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- EvexiTHROID
- Generic name (nonproprietary)
- levothyroxine and liothyronine
- Active ingredients
- Levothyroxine — 28.5 ug/1Liothyronine — 6.75 ug/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Trifluent Pharma, LLCNDC labeler code 73352
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Other FDA classes
- Thyroxine (Chemical structure)Triiodothyronine (Chemical structure)
- Identifiers
- Product ID 73352-695_40fa1a03-230d-b2c7-e063-6394a90a1268SPL ID 40fa1a03-230d-b2c7-e063-6394a90a1268SPL set ID 40fa228f-9bfc-fc71-e063-6394a90a9ab6RxCUI 198278, 208545, 313387, 313391, 313393, 314267, 2706319, 2706325, 2725187, 2725189, 2725191, 2725193, 2725195, 2725197, 2725199, 2725201UNII 06LU7C9H1V, Q51BO43MG4UPC 0373352696109, 0373352698103, 0373352699100, 0373352700103, 0373352693108, 0373352694105, 0373352697106
- Pharmacologic class
- l-Thyroxine; l-Triiodothyronine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N473352069510followed by a unit qualifier and the quantityPackage 73352-0695-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE EvexiTHROID (Thyroid Tablets, USP) are indicated: As replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. This category includes cretinism, myxedema, and ordinary hypothyroidism in patients of any age (children, adults, the elderly), or state (including pregnancy); primary hypothyroidism resulting from functional deficiency, primary atrophy, partial or total absence of thyroid gland, or the effects of surgery, radiation, or drugs, with or without the presence of goiter; and secondary (pituitary), or tertiary (hypothalamic) hypothyroidism (See WARNINGS ). As…
Excerpt only. Read the full label for complete information.
About NDC 73352-695
- What is NDC 73352-695?
- 73352-695 is the product NDC for EvexiTHROID, Levothyroxine 28.5 ug/1; Liothyronine 6.75 ug/1 tablet, listed with the FDA by Trifluent Pharma, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- EvexiTHROID (LEVOTHYROXINE and LIOTHYRONINE).
- What is the active ingredient?
- Levothyroxine, Liothyronine.
- Who is the labeler?
- Trifluent Pharma, LLC, NDC labeler code 73352. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for EvexiTHROID?
- 7 other product NDCs are listed under this name. See all EvexiTHROID NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other EvexiTHROID products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| EvexiTHROIDlevothyroxine and liothyronine | Levothyroxine 9.5 ug/1; Liothyronine 2.25 ug/1 | TabletOral | Trifluent Pharma, LLC | 73352-693 | 73352-0693-10 |
| EvexiTHROIDlevothyroxine and liothyronine | Levothyroxine 19 ug/1; Liothyronine 4.5 ug/1 | TabletOral | Trifluent Pharma, LLC | 73352-694 | 73352-0694-10 |
| EvexiTHROIDlevothyroxine and liothyronine | Levothyroxine 38 ug/1; Liothyronine 9 ug/1 | TabletOral | Trifluent Pharma, LLC | 73352-696 | 73352-0696-10 |
| EvexiTHROIDlevothyroxine and liothyronine | Levothyroxine 47.5 ug/1; Liothyronine 11.25 ug/1 | TabletOral | Trifluent Pharma, LLC | 73352-697 | 73352-0697-10 |
| EvexiTHROIDlevothyroxine and liothyronine | Levothyroxine 57 ug/1; Liothyronine 13.5 ug/1 | TabletOral | Trifluent Pharma, LLC | 73352-698 | 73352-0698-10 |
| EvexiTHROIDlevothyroxine and liothyronine | Levothyroxine 76 ug/1; Liothyronine 18 ug/1 | TabletOral | Trifluent Pharma, LLC | 73352-699 | 73352-0699-10 |
| EvexiTHROIDlevothyroxine and liothyronine | Levothyroxine 114 ug/1; Liothyronine 27 ug/1 | TabletOral | Trifluent Pharma, LLC | 73352-700 | 73352-0700-10 |